Duodenal–jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion

Lee, Wei-Jei; Almulaifi, Abdullah; Tsou, Jun-Juin; Ser, Kong-Han; Lee, Yi-Chih; Chen, Shuchun

doi:10.1016/j.soard.2014.12.017

Cited by 60 publications

(21 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other theoretical advantage of DJB-SG is related to the preservation of the pylorus, which include the prevention of dumping syndrome and facilitating the iron, calcium, vitamin B12, and protein absorption by preserving the acid and intrinsic factor. A recent study showed that by adding a duodenal exclusion to SG, the DJB-SG can increase 10% more weight loss and improve the glycemic control as well as reduce the uric acid level [47]. This finding further supported the important role of duodenum exclusion in the treatment of T2DM.…”

Section: New Bariatric/metabolic Proceduresmentioning

confidence: 62%

See 1 more Smart Citation

Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia

Lee

Aung

2016

Diabetes Metab J

Self Cite

View full text Add to dashboard Cite

Type 2 diabetes mellitus (T2DM) is a current global health priority and Asia is the epicenter of this epidemic disease. Unlike in the west, where older population is most affected, the burden of diabetes in Asian countries is disproportionately high in young to middle-age adults. The incidence of diabetic nephropathy is alarmingly high in patients with early onset T2DM, especially in those with poor glycemic control. How to control this chronic and debilitating disease is currently a very important health issue in Asia. Bariatric surgery has proven successful in treating not just obesity but also T2DM in morbid obese patients (body mass index [BMI] >35 kg/m2). Gastrointestinal metabolic surgery recently has been proposed as a new treatment modality for obesity related T2DM for patients with BMI <35 kg/m2. Many studies from Asia reported promising results of metabolic surgery to treat obese patients with T2DM which is not well controlled. It has been demonstrated that changes in gastrointestinal hormone secretion after gastrointestinal surgery would favor an early improvement of T2DM in Asians. New procedures have also been designed and proposed specifically for the treatment of diabetes in Asia. This article examines clinical trial data and accepted algorithms with a view toward elucidating the application of metabolic surgery for the treatment of T2DM in the Asia. We propose a systematic approach to surgical treatment, addressing current evidences, patient selection, procedure of choice, and timing and guideline for new procedures.

show abstract

Section: New Bariatric/metabolic Proceduresmentioning

confidence: 62%

“…In addition to the dramatic reduction of ghrelin effect, SG was also reported to have hind-gut effect with increasing of GLP-1 and PYY due to increasing transit time after SG [55]. It was also reported that weight loss to be similar between GB and SG but duodenum exclusion do play a role in T2DM remission [1247]. …”

Section: Mechanism Of Effectmentioning

confidence: 99%

Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia

Lee

Aung

2016

Diabetes Metab J

Self Cite

View full text Add to dashboard Cite

show abstract

“…One observational study investigated the comparative effect of SADI-S and RYGB, providing very low certainty evidence ( Supplementary Table S26) [120]. Similarly, one observational study addressed SADI-S versus BPD/DS (Supplementary Table S27) and one addressed SADI-S versus sleeve gastrectomy ( Supplementary Table S28) [121,122].…”

Section: Single Anastomosis Duodeno-ileal Bypass Withsleeve Gastrectomentioning

confidence: 99%

Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP

et al. 2020

View full text Add to dashboard Cite

Background Surgery for obesity and metabolic diseases has been evolved in the light of new scientific evidence, long-term outcomes and accumulated experience. EAES has sponsored an update of previous guidelines on bariatric surgery. Methods A multidisciplinary group of bariatric surgeons, obesity physicians, nutritional experts, psychologists, anesthetists and a patient representative comprised the guideline development panel. Development and reporting conformed to GRADE guidelines and AGREE II standards. Results Systematic review of databases, record selection, data extraction and synthesis, evidence appraisal and evidence-todecision frameworks were developed for 42 key questions in the domains Indication; Preoperative work-up; Perioperative management; Non-bypass, bypass and one-anastomosis procedures; Revisional surgery; Postoperative care; and Investigational procedures. A total of 36 recommendations and position statements were formed through a modified Delphi procedure. and Other Interventional Techniques Disclaimer This clinical practice guideline has been developed under the auspice of the European Association for Endoscopic Surgery (EAES). It is intended to be used primarily by health professionals (e.g. surgeons, anesthetists, physicians) and to assist in making informed clinical decisions on diagnostic measures and therapeutic management. It is also intended to inform individual practice of allied health professionals (e.g. surgical nurses, dietitians, physical rehabilitation therapists, psychologists); to inform strategic planning and resource management by healthcare authorities (e.g. regional and national authorities, healthcare institutions, hospital administration authorities); and to inform patients wishing to obtain an overview of the condition of interest and its management. The use of recommendations contained herein must be informed by supporting evidence accompanying each recommendation and by research evidence that might not have been published by the time of writing the present document. Users must thus base their actions informed by newly published evidence at any given point Electronic supplementary material The online version of this article (

show abstract

“…As far as T2DM remission rate is concerned, the LDJB-SG had a 92.3% total glycemic control rate compared to 86.2% in the SG alone group. The mean reduction in the HbA1c level for the LDJB-SG was likewise higher compared to the SG group (2.8 vs 2.1% p = 0.45) [13]. (Figure 28) …”

Section: Surgical Outcomesmentioning

confidence: 87%

Bariatric and Metabolic Surgery

Angrisani¹

2017

Updates in Surgery

View full text Add to dashboard Cite

Obesity as a global epidemic has rapidly increased in incidence in the recent few decades and represents one of the biggest public health challenges. Obesity plays a major risk for various diseases such as cardiovascular disease (CVD), diabetes mellitus (DM), hypercholesterolemia, osteoarthritis and some form of cancers. Bariatric and metabolic surgery provides the best solution for obesity and its associated comorbidities. This chapter will discuss in detail the commonly performed bariatric and metabolic surgeries.

show abstract

Duodenal–jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion

Cited by 60 publications

References 31 publications

Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia

Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia

Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP

Bariatric and Metabolic Surgery

Contact Info

Product

Resources

About